News & Updates

Show Multimedia Only
Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae

Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae

22 Apr 2023 byElvira Manzano

Sleep disruption following hospital admission for COVID-19 is associated with dyspnoea, anxiety, and muscle weakness in the CircCOVID cohort sub-study presented at ECCMID 2023.

Sleep disruption after COVID tied to dyspnoea, other post-acute sequelae

22 Apr 2023
Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients

Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients

21 Apr 2023 byStephen Padilla

In vaccinated adults with COVID-19 who are at higher risk of adverse outcomes, treatment with molnupiravir in addition to usual care falls short of reducing the rates of hospitalizations and deaths, as shown by the results of the PANORAMIC study.

Molnupiravir speeds up recovery, reduces viral load of vaccinated COVID-19 patients

21 Apr 2023
Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?

Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?

20 Apr 2023 byAudrey Abella

Mirvetuximab soravtansine (MIRV), an antibody drug conjugate (ADC), showed antitumour activity in women with platinum-resistant ovarian cancer* (PROC) with high folate receptor alpha (FRα) expression, findings from the phase III SORAYA study have shown.

Can an antibody-drug conjugate alter the treatment landscape of difficult-to-treat ovarian cancer?

20 Apr 2023